Introduction LENVAT 10 CAPSULE:

LENVAT 10 CAPSULE contains Lenvatinib which belongs to the group of medicines called Antineoplastic agents. LENVAT 10 CAPSULE is used on its own to manage locally recurrent/metastatic thyroid cancer in adults when radioactive iodine management becomes insufficient to stop the disease.

LENVAT 10 CAPSULE is also used on its own to manage liver cancer (hepatocellular carcinoma) when it becomes unresectable in adult patients. It is also used together with pembrolizumab (anticancer medicine) to manage endometrial carcinoma when cancer has spread and cannot be managed by surgery/radiation management. The medicine is also indicated for use in combination with everolimus (anticancer medicine) to manage advanced renal cell carcinoma (kidney cancer) in adults prior to anti-angiogenic therapy (cancer therapy).

LENVAT 10 CAPSULE is not recommended for use in patients allergic to Lenvatinib. Before taking LENVAT 10 CAPSULE, inform your doctor if you have high blood pressure, aneurysm (enlargement and weakening of blood vessel wall), history of blood clots in your arteries, heart diseases (such as congestive heart failure, heart attack), kidney diseases (such as mild/moderate/severe renal impairment), and/or liver diseases (such as mild/moderate/severe hepatic impairment).

LENVAT 10 CAPSULE is generally not recommended for use during pregnancy unless it is clearly necessary. It is also not recommended for use in breastfeeding women.

LENVAT 10 CAPSULE is not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 75 years/above) after consulting the doctor.

The most common side effects of taking LENVAT 10 CAPSULE are nausea, redness, rashes, peeling of skin, weight loss, vomiting, and/or hoarseness of voice. Consult your doctor if any of these symptoms worsen.

Uses of LENVAT 10 CAPSULE:

• Manage locally recurrent/metastatic thyroid cancer in adult patients.
• Manage unresectable liver cancer (hepatocellular carcinoma)
• Manage advanced endometrial carcinoma when used with pembrolizumab (anticancer medicine) in adults in whom the cancer has spread and cannot be removed by surgery/radiation management.
• Manage advanced renal cell carcinoma (kidney cancer) when used in combination with everolimus (anticancer medicine) following prior anti-angiogenic therapy in affected individuals

How to consume LENVAT 10 CAPSULE:

Take LENVAT 10 CAPSULE as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.